Zydus Cadila Ltd., of Ahmedabad, India, and Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, are partnering to tackle chikungunya, an emerging infectious disease in Africa, Asia and the Indian subcontinent. Terms are not disclosed, but the partnership agreement covers early stage development through the final commercialization of the vaccine. Read More

HONG KONG – Chinese authorities will participate in a cross-agency campaign to regularly publish a blacklist of companies and share information among multiple authorities to improve product safety of drugs and medical devices. Read More

HONG KONG – A structurally nanoengineered antimicrobial peptide polymer (SNAPP) showed great promise as an inexpensive but safe and effective antimicrobial, and may be a useful new weapon in the war against multidrug-resistant (MDR) gram-negative bacteria, an Australian study has found. Read More

TOKYO – India's Sun Pharmaceutical Industries Ltd. will be heading to Japan to sell generics and biosimilars in partnership with Mitsubishi Tanabe Pharma Corp., beginning in November. Read More

NEW DELHI – India is considering making its voluntary Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) mandatory to curb unfair marketing practices by pharma companies, including providing incentives for doctors to prescribe their products. Read More